The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes of patients with germ cell tumors diagnosed with stage I disease who subsequently received high dose chemotherapy (HDCT) with peripheral stem cell transplant (PBSCT) following failure of initial therapy for metastatic disease: The Indiana University experience.
 
Stephen B Benzinger
No Relationships to Disclose
 
Ryan Ashkar
No Relationships to Disclose
 
Rafat Abonour
Consulting or Advisory Role - BMS (Inst); Genentech; Janssen Oncology; Takeda
Research Funding - Janssen (Inst)
 
Mohammad Issam Abu Zaid
Stock and Other Ownership Interests - Pieris Pharmaceuticals
Consulting or Advisory Role - Syndax
Research Funding - Incyte (Inst); Janssen (Inst); Pharmacyclics (Inst); Syndax (Inst)
Travel, Accommodations, Expenses - Incyte; Janssen Oncology
 
Nabil Adra
Consulting or Advisory Role - Astellas Pharma
Research Funding - Genentech (Inst); Merck (Inst)
 
Lawrence H. Einhorn
Stock and Other Ownership Interests - Amgen; Biogen
 
Nasser H. Hanna
Honoraria - UpToDate
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Merck KGaA (Inst)
Other Relationship - BeyondSpring Pharmaceuticals; BeyondSpring Pharmaceuticals